HomeCompareTOKIF vs ADC

TOKIF vs ADC: Dividend Comparison 2026

TOKIF yields 35087.72% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TOKIF wins by $1.4045583093529018e+22M in total portfolio value
10 years
TOKIF
TOKIF
● Live price
35087.72%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4045583093529018e+22M
Annual income
$13,967,277,210,808,802,000,000,000,000.00
Full TOKIF calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — TOKIF vs ADC

📍 TOKIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTOKIFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TOKIF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TOKIF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TOKIF
Annual income on $10K today (after 15% tax)
$2,982,456.14/yr
After 10yr DRIP, annual income (after tax)
$11,872,185,629,187,480,000,000,000,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, TOKIF beats the other by $11,872,185,629,187,480,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TOKIF + ADC for your $10,000?

TOKIF: 50%ADC: 50%
100% ADC50/50100% TOKIF
Portfolio after 10yr
$7.022791546764509e+21M
Annual income
$6,983,638,605,404,401,000,000,000,000.00/yr
Blended yield
99.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

TOKIF
No analyst data
Altman Z
8.4
Piotroski
4/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TOKIF buys
0
ADC buys
0
No recent congressional trades found for TOKIF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTOKIFADC
Forward yield35087.72%4.11%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$1.4045583093529018e+22M$176.9K
Annual income after 10y$13,967,277,210,808,802,000,000,000,000.00$79,647.25
Total dividends collected$1.4040435209834525e+22M$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: TOKIF vs ADC ($10,000, DRIP)

YearTOKIF PortfolioTOKIF Income/yrADC PortfolioADC Income/yrGap
1← crossover$3,519,472$3,508,771.93$10,987$577.21+$3.51MTOKIF
2$1,157,880,257$1,154,114,421.98$12,293$855.34+$1157.87MTOKIF
3$356,094,180,688$354,855,248,813.21$14,088$1,290.70+$356094.17MTOKIF
4$102,373,625,569,446$101,992,604,796,109.58$16,660$1,994.91+$102373625.55MTOKIF
5$27,513,170,932,649,252$27,403,631,153,289,944.00$20,525$3,181.85+$27513170932.63MTOKIF
6$6,912,425,278,424,497,000$6,882,986,185,526,563,000.00$26,654$5,286.90+$6912425278424.47MTOKIF
7$1,623,550,972,939,442,000,000$1,616,154,677,891,527,600,000.00$37,006$9,259.47+$1623550972939442.00MTOKIF
8$356,497,181,763,681,700,000,000$354,759,982,222,636,500,000,000.00$55,862$17,338.74+$356497181763681664.00MTOKIF
9$73,183,067,962,816,976,000,000,000$72,801,615,978,329,840,000,000,000.00$93,452$35,300.32+$73183067962816978944.00MTOKIF
10$14,045,583,093,529,017,000,000,000,000$13,967,277,210,808,802,000,000,000,000.00$176,931$79,647.25+$1.4045583093529018e+22MTOKIF

TOKIF vs ADC: Complete Analysis 2026

TOKIFStock

Optima Medical Innovations Corp. produces and sells hemp-based cannabidiol (CBD) products in Canada and internationally. It offers industrial hemp-derived CBD oil, airless metered pens, capsules, topicals, and tinctures. The company also operates multidisciplinary pain clinics, which focuses on the treatment of chronic pain, including comprehensive, medical, and interventional pain management; independent medical evaluations; physiotherapy and chiropractic care; and medical cannabis and platelet rich plasma therapy, as well as mindfulness teaching. It has a research agreement with the Ryerson University for medical cannabis research and new medical grade products development. The company was formerly known as Tree of Knowledge International Corp. and changed its name to Optima Medical Innovations Corp. in November 2021. Optima Medical Innovations Corp. is based in Toronto, Canada.

Full TOKIF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this TOKIF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TOKIF vs SCHDTOKIF vs JEPITOKIF vs OTOKIF vs KOTOKIF vs MAINTOKIF vs NNNTOKIF vs EPRTTOKIF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.